- Home
- PROK vs CIO Comparison
PROK vs CIO Comparison
Compare PROK & CIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- CIO
- Stock Information
- Founded
- PROK 2015
- CIO 2013
- Country
- PROK United States
- CIO Canada
- Employees
- PROK N/A
- CIO N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- CIO Real Estate Investment Trusts
- Sector
- PROK Health Care
- CIO Real Estate
- Exchange
- PROK Nasdaq
- CIO Nasdaq
- Market Cap
- PROK 220.6M
- CIO 230.9M
- IPO Year
- PROK N/A
- CIO 2014
- Fundamental
- Price
- PROK $1.70
- CIO $4.88
- Analyst Decision
- PROK Buy
- CIO
- Analyst Count
- PROK 5
- CIO 0
- Target Price
- PROK $4.50
- CIO N/A
- AVG Volume (30 Days)
- PROK 437.3K
- CIO 199.8K
- Earning Date
- PROK 11-12-2024
- CIO 10-31-2024
- Dividend Yield
- PROK N/A
- CIO 8.18%
- EPS Growth
- PROK N/A
- CIO N/A
- EPS
- PROK N/A
- CIO N/A
- Revenue
- PROK N/A
- CIO $173,528,000.00
- Revenue This Year
- PROK N/A
- CIO N/A
- Revenue Next Year
- PROK N/A
- CIO $0.25
- P/E Ratio
- PROK N/A
- CIO N/A
- Revenue Growth
- PROK N/A
- CIO N/A
- 52 Week Low
- PROK $1.12
- CIO $4.02
- 52 Week High
- PROK $4.44
- CIO $6.71
- Technical
- Relative Strength Index (RSI)
- PROK 43.50
- CIO 32.25
- Support Level
- PROK $1.95
- CIO $5.01
- Resistance Level
- PROK $2.27
- CIO $5.43
- Average True Range (ATR)
- PROK 0.18
- CIO 0.21
- MACD
- PROK 0.03
- CIO -0.04
- Stochastic Oscillator
- PROK 26.45
- CIO 7.38
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.
About CIO City Office REIT Inc.
City Office REIT Inc is a real estate investment trust. It is focused on acquiring, owning, and operating high-quality office properties located predominantly in Sun Belt markets. The principal objective of the company is to provide attractive risk-adjusted returns to its investors over the long-term through a combination of dividends and capital appreciation. The company owns office buildings in the metropolitan areas of Dallas, Denver, Orlando, Phoenix, Portland, Raleigh, San Diego, Seattle, and Tampa.